

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.49952763 |
| 2 | cellular potassium ion homeostasis (GO:0030007) | 5.28504582 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.26531751 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.20258547 |
| 5 | sodium ion export (GO:0071436) | 4.98222891 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.84535257 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.76510975 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.75944175 |
| 9 | glutamate secretion (GO:0014047) | 4.65280390 |
| 10 | vocalization behavior (GO:0071625) | 4.60510271 |
| 11 | gamma-aminobutyric acid transport (GO:0015812) | 4.57649132 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.47188121 |
| 13 | L-amino acid import (GO:0043092) | 4.43739648 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.41483021 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.39316166 |
| 16 | axon ensheathment in central nervous system (GO:0032291) | 4.37934056 |
| 17 | central nervous system myelination (GO:0022010) | 4.37934056 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.35660139 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.33696787 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.30381706 |
| 21 | cell communication by electrical coupling (GO:0010644) | 4.18150439 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.18118241 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.12156082 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.11865946 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.07619859 |
| 26 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07511490 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.07208073 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.06037313 |
| 29 | protein localization to synapse (GO:0035418) | 4.00863185 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.96379996 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.92309513 |
| 32 | presynaptic membrane organization (GO:0097090) | 3.91762418 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91090431 |
| 34 | alanine transport (GO:0032328) | 3.90122607 |
| 35 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.88664574 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.86110062 |
| 37 | amino acid import (GO:0043090) | 3.86042316 |
| 38 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.84848763 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83211544 |
| 40 | potassium ion import (GO:0010107) | 3.82945388 |
| 41 | exploration behavior (GO:0035640) | 3.82863198 |
| 42 | response to auditory stimulus (GO:0010996) | 3.82625854 |
| 43 | layer formation in cerebral cortex (GO:0021819) | 3.81500939 |
| 44 | proline transport (GO:0015824) | 3.75910026 |
| 45 | potassium ion homeostasis (GO:0055075) | 3.71963177 |
| 46 | C4-dicarboxylate transport (GO:0015740) | 3.68685005 |
| 47 | serotonin metabolic process (GO:0042428) | 3.68297431 |
| 48 | cellular sodium ion homeostasis (GO:0006883) | 3.67169322 |
| 49 | neuron-neuron synaptic transmission (GO:0007270) | 3.65603225 |
| 50 | long-term memory (GO:0007616) | 3.64944868 |
| 51 | neurotransmitter transport (GO:0006836) | 3.56786735 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.55871666 |
| 53 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.55173922 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.53488865 |
| 55 | auditory behavior (GO:0031223) | 3.50504905 |
| 56 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.48015025 |
| 57 | primary amino compound metabolic process (GO:1901160) | 3.44993893 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44174871 |
| 59 | startle response (GO:0001964) | 3.39109401 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38810017 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33895484 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.32462775 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.31847471 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.30431348 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 3.28685358 |
| 66 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.26491617 |
| 67 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.26029098 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.22954854 |
| 69 | glycine transport (GO:0015816) | 3.22521584 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22501198 |
| 71 | neuromuscular process controlling posture (GO:0050884) | 3.21509030 |
| 72 | activation of protein kinase A activity (GO:0034199) | 3.21400028 |
| 73 | synaptic transmission (GO:0007268) | 3.21120377 |
| 74 | regulation of synapse maturation (GO:0090128) | 3.20997340 |
| 75 | regulation of synaptic plasticity (GO:0048167) | 3.18474907 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.18438699 |
| 77 | dendrite morphogenesis (GO:0048813) | 3.18125001 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.18070854 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.17759483 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 3.17540767 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.17130542 |
| 82 | behavioral response to nicotine (GO:0035095) | 3.16721808 |
| 83 | synaptic vesicle endocytosis (GO:0048488) | 3.15146931 |
| 84 | response to pheromone (GO:0019236) | 3.14571129 |
| 85 | prepulse inhibition (GO:0060134) | 3.13959172 |
| 86 | regulation of neurotransmitter uptake (GO:0051580) | 3.13921891 |
| 87 | positive regulation of membrane potential (GO:0045838) | 3.13444411 |
| 88 | negative regulation of astrocyte differentiation (GO:0048712) | 3.12866700 |
| 89 | response to histamine (GO:0034776) | 3.12624140 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 3.12585155 |
| 91 | adult walking behavior (GO:0007628) | 3.10975901 |
| 92 | regulation of neurotransmitter secretion (GO:0046928) | 3.10775372 |
| 93 | cerebellar granule cell differentiation (GO:0021707) | 3.09410298 |
| 94 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.08457496 |
| 95 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.08250422 |
| 96 | cell differentiation in hindbrain (GO:0021533) | 3.06677956 |
| 97 | regulation of postsynaptic membrane potential (GO:0060078) | 3.06052432 |
| 98 | acidic amino acid transport (GO:0015800) | 3.05678672 |
| 99 | neurotransmitter uptake (GO:0001504) | 3.04601864 |
| 100 | membrane hyperpolarization (GO:0060081) | 3.02947252 |
| 101 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02706311 |
| 102 | neuron recognition (GO:0008038) | 3.01262231 |
| 103 | cellular potassium ion transport (GO:0071804) | 2.99645006 |
| 104 | potassium ion transmembrane transport (GO:0071805) | 2.99645006 |
| 105 | detection of calcium ion (GO:0005513) | 2.99419667 |
| 106 | axonal fasciculation (GO:0007413) | 2.98909577 |
| 107 | regulation of vesicle fusion (GO:0031338) | 2.98365761 |
| 108 | regulation of beta-amyloid formation (GO:1902003) | 2.97905927 |
| 109 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.97105144 |
| 110 | regulation of dendritic spine development (GO:0060998) | 2.95497601 |
| 111 | regulation of neurotransmitter transport (GO:0051588) | 2.95449460 |
| 112 | behavioral response to cocaine (GO:0048148) | 2.94250617 |
| 113 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94102960 |
| 114 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.94066093 |
| 115 | positive regulation of synapse maturation (GO:0090129) | 2.93869068 |
| 116 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.93027598 |
| 117 | postsynaptic membrane organization (GO:0001941) | 2.92711178 |
| 118 | regulation of synaptic transmission (GO:0050804) | 2.90988386 |
| 119 | membrane repolarization (GO:0086009) | 2.87457899 |
| 120 | neuronal ion channel clustering (GO:0045161) | 2.84745314 |
| 121 | synapse assembly (GO:0007416) | 2.84019605 |
| 122 | mechanosensory behavior (GO:0007638) | 2.83697270 |
| 123 | regulation of membrane repolarization (GO:0060306) | 2.83255525 |
| 124 | membrane depolarization (GO:0051899) | 2.83180346 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82678968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.49613509 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.28686681 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07617647 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03988123 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88538683 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67341304 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67341304 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65398833 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60819446 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60619964 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57124096 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51883081 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49664211 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47761939 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44362179 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35566792 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35154101 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.29264467 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24239486 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22119485 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20978981 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.17615697 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07615235 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05153363 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83292353 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76218304 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73470712 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70942316 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67638215 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60730074 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58408097 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58124042 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57630012 |
| 34 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56373891 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53678381 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50784334 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47744880 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43227058 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40725798 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38152814 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35979638 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34519478 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33739342 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31619855 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30799608 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28844715 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28548304 |
| 48 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.28276997 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27251345 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26671190 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24667062 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24029596 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23251448 |
| 54 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22871452 |
| 55 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22645013 |
| 56 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22620849 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21200297 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19855725 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19689477 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19567405 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18419039 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18125376 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18106012 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17086433 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14339950 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14037974 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11934098 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11688814 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09478469 |
| 70 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09396052 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09082179 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08239970 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06710531 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05157750 |
| 75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04901629 |
| 76 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04492234 |
| 77 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03764050 |
| 78 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02204547 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02112393 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01859787 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01227412 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01206173 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00948157 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99170787 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98171594 |
| 86 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98112482 |
| 87 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98027438 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97495515 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97320036 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97109373 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97109373 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96445195 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96065476 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95422776 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95422776 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94988157 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94680383 |
| 98 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94104116 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93877853 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93695731 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93261341 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93230864 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92696512 |
| 104 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92627711 |
| 105 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92325225 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91569373 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90861082 |
| 108 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90594234 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90492728 |
| 110 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.90384873 |
| 111 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.89667529 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 0.89409615 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88150215 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86633722 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86528293 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84697578 |
| 117 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84341277 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83762828 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83574011 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82567012 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81902874 |
| 122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.81678852 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81284216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.56235756 |
| 2 | MP0003880_abnormal_central_pattern | 3.92001567 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.81607112 |
| 4 | MP0004270_analgesia | 3.37604214 |
| 5 | MP0009046_muscle_twitch | 3.31497105 |
| 6 | MP0009745_abnormal_behavioral_response | 3.12098509 |
| 7 | MP0001984_abnormal_olfaction | 3.10060989 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.09964855 |
| 9 | MP0002064_seizures | 2.99631790 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.97512910 |
| 11 | MP0001486_abnormal_startle_reflex | 2.85660954 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.62956886 |
| 13 | MP0002272_abnormal_nervous_system | 2.53692302 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.52821473 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.49063312 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.47691920 |
| 17 | MP0002822_catalepsy | 2.43146039 |
| 18 | MP0003329_amyloid_beta_deposits | 2.25283848 |
| 19 | MP0004147_increased_porphyrin_level | 2.25046626 |
| 20 | MP0008569_lethality_at_weaning | 2.13869531 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.12510046 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.08799928 |
| 23 | MP0004885_abnormal_endolymph | 2.03727513 |
| 24 | MP0004858_abnormal_nervous_system | 2.02269661 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.97905468 |
| 26 | MP0002736_abnormal_nociception_after | 1.96043535 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.95412049 |
| 28 | MP0003690_abnormal_glial_cell | 1.91235637 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.88588972 |
| 30 | MP0001502_abnormal_circadian_rhythm | 1.82007125 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.81538019 |
| 32 | MP0001970_abnormal_pain_threshold | 1.78613551 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.76924744 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.74478067 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.71344914 |
| 36 | MP0000778_abnormal_nervous_system | 1.65738030 |
| 37 | MP0002184_abnormal_innervation | 1.65206499 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.61877296 |
| 39 | MP0004924_abnormal_behavior | 1.61877296 |
| 40 | MP0003633_abnormal_nervous_system | 1.60614927 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.55604528 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.52627807 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.50682121 |
| 44 | MP0000955_abnormal_spinal_cord | 1.45578323 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.44780499 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.43371617 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.43071831 |
| 48 | MP0004142_abnormal_muscle_tone | 1.41741455 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.36776210 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.34507330 |
| 51 | MP0003631_nervous_system_phenotype | 1.32229290 |
| 52 | MP0003634_abnormal_glial_cell | 1.30012999 |
| 53 | MP0005253_abnormal_eye_physiology | 1.24462009 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.24194820 |
| 55 | MP0002229_neurodegeneration | 1.21480744 |
| 56 | MP0001529_abnormal_vocalization | 1.18452660 |
| 57 | MP0002090_abnormal_vision | 1.14915038 |
| 58 | MP0002152_abnormal_brain_morphology | 1.14349777 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.14192588 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.13811868 |
| 61 | MP0001905_abnormal_dopamine_level | 1.13198280 |
| 62 | MP0000751_myopathy | 1.12486875 |
| 63 | MP0003879_abnormal_hair_cell | 1.10495254 |
| 64 | MP0003075_altered_response_to | 1.09487319 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.06607594 |
| 66 | MP0005499_abnormal_olfactory_system | 1.06607594 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.05982848 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.05978829 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.02138215 |
| 70 | MP0003632_abnormal_nervous_system | 1.01811216 |
| 71 | MP0000604_amyloidosis | 1.01721018 |
| 72 | MP0002752_abnormal_somatic_nervous | 0.99352486 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.97911600 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.96549126 |
| 75 | MP0003011_delayed_dark_adaptation | 0.92430922 |
| 76 | MP0004742_abnormal_vestibular_system | 0.90328617 |
| 77 | MP0004043_abnormal_pH_regulation | 0.88884170 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.88251521 |
| 79 | MP0004130_abnormal_muscle_cell | 0.87788146 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.81925477 |
| 81 | MP0001177_atelectasis | 0.81862900 |
| 82 | MP0008872_abnormal_physiological_respon | 0.81722573 |
| 83 | MP0005410_abnormal_fertilization | 0.81546735 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.80361829 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.80267063 |
| 86 | MP0000920_abnormal_myelination | 0.78954655 |
| 87 | MP0003646_muscle_fatigue | 0.78045913 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.76563493 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.75298391 |
| 90 | MP0004085_abnormal_heartbeat | 0.75117955 |
| 91 | MP0008874_decreased_physiological_sensi | 0.74137739 |
| 92 | MP0003121_genomic_imprinting | 0.73212539 |
| 93 | MP0003123_paternal_imprinting | 0.72990325 |
| 94 | MP0004233_abnormal_muscle_weight | 0.72919928 |
| 95 | MP0003136_yellow_coat_color | 0.72591122 |
| 96 | MP0005535_abnormal_body_temperature | 0.72210008 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.72190018 |
| 98 | MP0003787_abnormal_imprinting | 0.71472904 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.70391889 |
| 100 | MP0003195_calcinosis | 0.68116080 |
| 101 | MP0005195_abnormal_posterior_eye | 0.63593358 |
| 102 | MP0000026_abnormal_inner_ear | 0.62906474 |
| 103 | MP0003122_maternal_imprinting | 0.62103730 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62038468 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.60655037 |
| 106 | MP0004133_heterotaxia | 0.60518932 |
| 107 | MP0001188_hyperpigmentation | 0.59497930 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.57619041 |
| 109 | MP0003878_abnormal_ear_physiology | 0.55857968 |
| 110 | MP0005377_hearing/vestibular/ear_phenot | 0.55857968 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.54105531 |
| 112 | MP0001943_abnormal_respiration | 0.53674884 |
| 113 | MP0002102_abnormal_ear_morphology | 0.53101806 |
| 114 | MP0003861_abnormal_nervous_system | 0.52927750 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.52819179 |
| 116 | MP0001664_abnormal_digestion | 0.52729134 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.50781845 |
| 118 | MP0003045_fibrosis | 0.49592084 |
| 119 | MP0003283_abnormal_digestive_organ | 0.49281774 |
| 120 | MP0010769_abnormal_survival | 0.47471118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.00994614 |
| 2 | Myokymia (HP:0002411) | 5.91558988 |
| 3 | Focal seizures (HP:0007359) | 5.09129712 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.63299345 |
| 5 | Visual hallucinations (HP:0002367) | 4.38291939 |
| 6 | Febrile seizures (HP:0002373) | 4.13758782 |
| 7 | Megalencephaly (HP:0001355) | 4.09928430 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.07491834 |
| 9 | Hemiparesis (HP:0001269) | 4.03890495 |
| 10 | Action tremor (HP:0002345) | 3.98782207 |
| 11 | Atonic seizures (HP:0010819) | 3.94485597 |
| 12 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.82680965 |
| 13 | Aplasia of the phalanges of the hand (HP:0009802) | 3.82680965 |
| 14 | Aplasia involving bones of the extremities (HP:0009825) | 3.82680965 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.70410353 |
| 16 | Absence seizures (HP:0002121) | 3.65436840 |
| 17 | Diplopia (HP:0000651) | 3.64003997 |
| 18 | Abnormality of binocular vision (HP:0011514) | 3.64003997 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.61238382 |
| 20 | Hemiplegia (HP:0002301) | 3.48523222 |
| 21 | Dialeptic seizures (HP:0011146) | 3.45266950 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.44732024 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.28190603 |
| 24 | Truncal ataxia (HP:0002078) | 3.08974881 |
| 25 | Depression (HP:0000716) | 3.00088259 |
| 26 | Postural instability (HP:0002172) | 2.94911641 |
| 27 | Abnormal eating behavior (HP:0100738) | 2.94398027 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.88924036 |
| 29 | Ankle clonus (HP:0011448) | 2.82907641 |
| 30 | Dysmetria (HP:0001310) | 2.79789994 |
| 31 | Broad-based gait (HP:0002136) | 2.75615629 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.70355384 |
| 33 | Status epilepticus (HP:0002133) | 2.69293201 |
| 34 | Anxiety (HP:0000739) | 2.67455233 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.60027337 |
| 36 | Hyperventilation (HP:0002883) | 2.59157165 |
| 37 | Intention tremor (HP:0002080) | 2.56575350 |
| 38 | Poor eye contact (HP:0000817) | 2.48845172 |
| 39 | Absent speech (HP:0001344) | 2.46999693 |
| 40 | Increased circulating renin level (HP:0000848) | 2.42583034 |
| 41 | Impaired smooth pursuit (HP:0007772) | 2.41220633 |
| 42 | Inability to walk (HP:0002540) | 2.40760256 |
| 43 | Cerebral hypomyelination (HP:0006808) | 2.39680816 |
| 44 | Abnormality of the corticospinal tract (HP:0002492) | 2.38397729 |
| 45 | Impaired social interactions (HP:0000735) | 2.36451661 |
| 46 | Abnormal social behavior (HP:0012433) | 2.36451661 |
| 47 | Bradykinesia (HP:0002067) | 2.34731064 |
| 48 | Scanning speech (HP:0002168) | 2.32124553 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.26759017 |
| 50 | Akinesia (HP:0002304) | 2.25126938 |
| 51 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.23975024 |
| 52 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.22072841 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20404282 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20404282 |
| 55 | Genetic anticipation (HP:0003743) | 2.19479192 |
| 56 | Clumsiness (HP:0002312) | 2.19035098 |
| 57 | Central scotoma (HP:0000603) | 2.18265925 |
| 58 | Mutism (HP:0002300) | 2.13029292 |
| 59 | Scotoma (HP:0000575) | 2.12767646 |
| 60 | Torticollis (HP:0000473) | 2.11542502 |
| 61 | Pheochromocytoma (HP:0002666) | 2.11033835 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.10991551 |
| 63 | Stereotypic behavior (HP:0000733) | 2.10815794 |
| 64 | Humeroradial synostosis (HP:0003041) | 2.10704851 |
| 65 | Synostosis involving the elbow (HP:0003938) | 2.10704851 |
| 66 | Delusions (HP:0000746) | 2.10134365 |
| 67 | Confusion (HP:0001289) | 2.09392135 |
| 68 | Polyphagia (HP:0002591) | 2.09336673 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.08475212 |
| 70 | Drooling (HP:0002307) | 2.08243697 |
| 71 | Excessive salivation (HP:0003781) | 2.08243697 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07678595 |
| 73 | Decreased central vision (HP:0007663) | 2.05821651 |
| 74 | Gait imbalance (HP:0002141) | 2.05308148 |
| 75 | Spastic gait (HP:0002064) | 2.04373129 |
| 76 | Retinal dysplasia (HP:0007973) | 2.03526110 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.03148323 |
| 78 | Polydipsia (HP:0001959) | 2.03047751 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.03047751 |
| 80 | Sleep apnea (HP:0010535) | 2.03009386 |
| 81 | Abnormality of the lower motor neuron (HP:0002366) | 2.02770476 |
| 82 | Urinary urgency (HP:0000012) | 2.01234310 |
| 83 | Exercise-induced myalgia (HP:0003738) | 1.98814332 |
| 84 | Amblyopia (HP:0000646) | 1.98574013 |
| 85 | Progressive inability to walk (HP:0002505) | 1.96908098 |
| 86 | Hypsarrhythmia (HP:0002521) | 1.96882174 |
| 87 | Abnormality of macular pigmentation (HP:0008002) | 1.96731678 |
| 88 | Type II lissencephaly (HP:0007260) | 1.95597494 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 1.94578012 |
| 90 | Focal dystonia (HP:0004373) | 1.93750909 |
| 91 | Metabolic alkalosis (HP:0200114) | 1.91858006 |
| 92 | Tetraplegia (HP:0002445) | 1.91545756 |
| 93 | Rigidity (HP:0002063) | 1.91147564 |
| 94 | Molar tooth sign on MRI (HP:0002419) | 1.91144229 |
| 95 | Abnormality of midbrain morphology (HP:0002418) | 1.91144229 |
| 96 | Congenital stationary night blindness (HP:0007642) | 1.90062179 |
| 97 | Limb dystonia (HP:0002451) | 1.89734146 |
| 98 | Prolonged QT interval (HP:0001657) | 1.88875289 |
| 99 | Impaired vibratory sensation (HP:0002495) | 1.88586286 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.88459003 |
| 101 | Protruding tongue (HP:0010808) | 1.88190229 |
| 102 | Medial flaring of the eyebrow (HP:0010747) | 1.86785154 |
| 103 | Dyskinesia (HP:0100660) | 1.84764079 |
| 104 | Pancreatic fibrosis (HP:0100732) | 1.84273547 |
| 105 | Pancreatic cysts (HP:0001737) | 1.84087217 |
| 106 | Dysmetric saccades (HP:0000641) | 1.83151905 |
| 107 | Papilledema (HP:0001085) | 1.82982385 |
| 108 | Abnormal EKG (HP:0003115) | 1.82310710 |
| 109 | Agitation (HP:0000713) | 1.82146244 |
| 110 | Spastic tetraplegia (HP:0002510) | 1.81707086 |
| 111 | Annular pancreas (HP:0001734) | 1.81179426 |
| 112 | Gait ataxia (HP:0002066) | 1.80960175 |
| 113 | True hermaphroditism (HP:0010459) | 1.80862650 |
| 114 | CNS hypomyelination (HP:0003429) | 1.80777806 |
| 115 | Insomnia (HP:0100785) | 1.80614587 |
| 116 | Clonus (HP:0002169) | 1.79530138 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 1.79100672 |
| 118 | Narrow nasal bridge (HP:0000446) | 1.78531981 |
| 119 | Congenital primary aphakia (HP:0007707) | 1.78529749 |
| 120 | Abnormality of saccadic eye movements (HP:0000570) | 1.78323852 |
| 121 | Nephronophthisis (HP:0000090) | 1.78321448 |
| 122 | Fetal akinesia sequence (HP:0001989) | 1.78277257 |
| 123 | Split foot (HP:0001839) | 1.77222709 |
| 124 | Specific learning disability (HP:0001328) | 1.76695929 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.74573285 |
| 126 | Incomplete penetrance (HP:0003829) | 1.72434210 |
| 127 | Spinal canal stenosis (HP:0003416) | 1.71171412 |
| 128 | Limb ataxia (HP:0002070) | 1.70855942 |
| 129 | Craniofacial dystonia (HP:0012179) | 1.69403596 |
| 130 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69396674 |
| 131 | Absent/shortened dynein arms (HP:0200106) | 1.69396674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.56306527 |
| 2 | NTRK3 | 4.01812675 |
| 3 | MAP3K9 | 2.95109101 |
| 4 | FRK | 2.91986394 |
| 5 | NTRK2 | 2.83047531 |
| 6 | MAP3K4 | 2.68831416 |
| 7 | PHKG1 | 2.68178898 |
| 8 | PHKG2 | 2.68178898 |
| 9 | MARK1 | 2.59256139 |
| 10 | MINK1 | 2.51172861 |
| 11 | TNIK | 2.48841324 |
| 12 | LMTK2 | 2.46671934 |
| 13 | PRKD3 | 2.41040433 |
| 14 | MAP2K7 | 2.26814685 |
| 15 | PAK6 | 2.05007202 |
| 16 | DAPK2 | 1.95480773 |
| 17 | CAMKK1 | 1.78542199 |
| 18 | CASK | 1.72509952 |
| 19 | MAP2K4 | 1.64345951 |
| 20 | STK38 | 1.56833596 |
| 21 | NTRK1 | 1.50935135 |
| 22 | CDK5 | 1.46881967 |
| 23 | MAPK13 | 1.45820960 |
| 24 | KSR2 | 1.44960742 |
| 25 | PINK1 | 1.38717781 |
| 26 | MUSK | 1.37540231 |
| 27 | PRKCG | 1.35127538 |
| 28 | PRPF4B | 1.32984743 |
| 29 | ADRBK2 | 1.30734918 |
| 30 | RIPK4 | 1.30343900 |
| 31 | CAMKK2 | 1.28363111 |
| 32 | SGK223 | 1.28280769 |
| 33 | SGK494 | 1.28280769 |
| 34 | MAP3K12 | 1.23934644 |
| 35 | SGK2 | 1.22383475 |
| 36 | GRK5 | 1.14146698 |
| 37 | TYRO3 | 1.11042828 |
| 38 | KSR1 | 1.09884994 |
| 39 | SIK2 | 1.04946370 |
| 40 | FES | 1.04640622 |
| 41 | PNCK | 1.03030420 |
| 42 | SGK3 | 1.02053519 |
| 43 | MAP4K2 | 0.98238207 |
| 44 | CDK19 | 0.96750052 |
| 45 | CAMK2A | 0.96487168 |
| 46 | GRK1 | 0.96357818 |
| 47 | PLK2 | 0.96021815 |
| 48 | DAPK1 | 0.94982291 |
| 49 | MAP3K13 | 0.94222778 |
| 50 | ARAF | 0.89938577 |
| 51 | WNK4 | 0.88436248 |
| 52 | PRKCH | 0.88246600 |
| 53 | BMPR1B | 0.86718080 |
| 54 | CAMK1 | 0.85791028 |
| 55 | TAOK3 | 0.84404850 |
| 56 | DYRK1A | 0.83703956 |
| 57 | WNK1 | 0.83522476 |
| 58 | UHMK1 | 0.83506407 |
| 59 | WNK3 | 0.82328837 |
| 60 | STK39 | 0.82206734 |
| 61 | PKN1 | 0.81914857 |
| 62 | CAMK2B | 0.80373443 |
| 63 | STK11 | 0.79768346 |
| 64 | PAK3 | 0.79402625 |
| 65 | CDK15 | 0.78707234 |
| 66 | CDK18 | 0.77804055 |
| 67 | MAP3K2 | 0.74656508 |
| 68 | TNK2 | 0.73111774 |
| 69 | CDK14 | 0.71964350 |
| 70 | SGK1 | 0.71564050 |
| 71 | CAMK2G | 0.71346854 |
| 72 | MAPK12 | 0.69913720 |
| 73 | CDC42BPA | 0.68383004 |
| 74 | CDK11A | 0.66841125 |
| 75 | DYRK2 | 0.66037352 |
| 76 | INSRR | 0.64919727 |
| 77 | MARK2 | 0.64548600 |
| 78 | CAMK1G | 0.63898736 |
| 79 | CAMK2D | 0.62811529 |
| 80 | MAP3K7 | 0.61084025 |
| 81 | TXK | 0.60864247 |
| 82 | PDK4 | 0.59536156 |
| 83 | PDK3 | 0.59536156 |
| 84 | OXSR1 | 0.59080766 |
| 85 | PRKCE | 0.58578513 |
| 86 | RPS6KA3 | 0.57961852 |
| 87 | PDPK1 | 0.57882415 |
| 88 | PDK1 | 0.57791653 |
| 89 | RET | 0.57488408 |
| 90 | MAP2K6 | 0.57431901 |
| 91 | RIPK1 | 0.55407311 |
| 92 | TAOK1 | 0.54461161 |
| 93 | NEK1 | 0.53565885 |
| 94 | NEK6 | 0.52486596 |
| 95 | MAP3K11 | 0.52004068 |
| 96 | PIK3CA | 0.49623047 |
| 97 | CSNK1G2 | 0.48960060 |
| 98 | PTK2B | 0.48345034 |
| 99 | MAPK10 | 0.46978409 |
| 100 | MAPKAPK5 | 0.46926083 |
| 101 | PRKCQ | 0.46794384 |
| 102 | LATS2 | 0.45277426 |
| 103 | PRKCZ | 0.44954157 |
| 104 | ROCK2 | 0.44900841 |
| 105 | TRIB3 | 0.44472607 |
| 106 | CAMK4 | 0.43790013 |
| 107 | CSNK1D | 0.42495072 |
| 108 | FYN | 0.41959254 |
| 109 | BMPR2 | 0.41900380 |
| 110 | FGFR2 | 0.41857288 |
| 111 | PRKCA | 0.41313891 |
| 112 | CSNK1A1 | 0.40916011 |
| 113 | CSNK1G3 | 0.40407449 |
| 114 | ADRBK1 | 0.39964144 |
| 115 | FGR | 0.39569071 |
| 116 | ALK | 0.39065700 |
| 117 | PRKACA | 0.38806567 |
| 118 | ROCK1 | 0.38546235 |
| 119 | CSNK1A1L | 0.36103052 |
| 120 | PRKG1 | 0.35802090 |
| 121 | ERBB2 | 0.35495022 |
| 122 | PRKCB | 0.35133105 |
| 123 | CSNK1G1 | 0.34258916 |
| 124 | MAP2K1 | 0.33427302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.68445129 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.22177598 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.12745360 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.85505333 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.85211903 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61591227 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.55023695 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52011370 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.44009850 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.37853373 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.26312162 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19855441 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.16212143 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14023104 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05166930 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.01466989 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82888700 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.73320631 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68916478 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67071287 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61444765 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57636829 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.54452012 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53567418 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.51882184 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43997123 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41542068 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41123773 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39807442 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.38462885 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32592120 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23653848 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.18020916 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14315373 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12361864 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05523673 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04684199 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04125010 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02800421 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01820529 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00201845 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 0.98863813 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98289811 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93855177 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92535091 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.92449864 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91572665 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88145893 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88094842 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86709941 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84694973 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84012905 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81770486 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81062603 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.77754489 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77715531 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75835481 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74959115 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.73814495 |
| 60 | * Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72912013 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71710264 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71569775 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70877994 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70489457 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68305748 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68183930 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67462888 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66527512 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65253201 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63829689 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62696153 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62501407 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.61840615 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59589272 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59585547 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58880195 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58507440 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56576495 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.55207680 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54536549 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54448247 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54274005 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54164692 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53510160 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52625964 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50202051 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48483346 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46474433 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46396045 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45620352 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43789641 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.40555147 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40520983 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39984356 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39224258 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39219028 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38683067 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36021418 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35386621 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34629454 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34126862 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33377306 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32372219 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32068609 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30534626 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.29789483 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29770107 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28166249 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28103733 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28093535 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26230089 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24020218 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22593538 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22583613 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22468963 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.22285543 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.21575676 |

